Norway· NO-ID_7590325F-4A65-4CC2-8B53-47CC82D91533
Vecuronium inresa
A vecuronium product containing vecuronium bromide, registered in Norway by Inresa Arzneimittel. The same ATC class is registered in 6 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Vecuronium is registered in 6 of 19 countries.
Countries holding a registration under ATC M03AC03 (vecuronium), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 3 of them publish a price we can compare per daily dose
Vecuronium · ATC M03AC03
6 / 19 countries
- Finlandprice
- Germany
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Vecuronium Bromide
- Manufacturer
- Inresa Arzneimittel
- Country
- Norway (NO)
- ATC code
- M03AC03
- ATC class
- Vecuronium
- Defined daily dose
- 6.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 2
- no_merkevare_idID_7590325F-4A65-4CC2-8B53-47CC82D91533
- no_varenummer32172110 x 10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
125 interactions on record for vecuronium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vecuronium · interactions on record
125 records
- 12 severe
- 59 moderate
- 4 minor
- 50 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vecuronium in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNorcuron 10mg powder and solvent for solution for injection vialsOrganon Pharma (UK) Ltd
- FinlandNorcuronN.V. Organon
- United Statesvecuronium bromideSun Pharmaceutical Industries, Inc.
- GermanyVecuronium BradexBradex S.A.
- NetherlandsVecuronium SUN 10 mg poeder voor oplossing voor injectie en intraveneuze infusieSun Pharmaceutical Industries Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Vecuronium Bradex, Vecuronium Inresa
- United Kingdom (Northern Ireland) · Vecuronium Bromide, Vecuronium Bromide Bradex
- Greece · Vecurol
- Croatia · Veculex
- Netherlands · Vecuronium Sun
- Portugal · Brometo De Vecurónio Bradex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b1cc1878-8048-4efc-b536-bc029b85c7ae GET /v1/drugs/b1cc1878-8048-4efc-b536-bc029b85c7ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Vekuronium",
"merkevare_id": "ID_7590325F-4A65-4CC2-8B53-47CC82D91533",
"name_form_strength": "Vecuronium inresa pulv til inj væske, oppl 10 mg",
"prescription_group": "C"
}See everything about vecuronium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.